Trade Summary

1 week ago, Bellon Christine, serving as GC at Beam Therapeutics Inc. (BEAM), sold 5,956 shares at $24.58 per share, for a total transaction value of $146,398.00. Following this transaction, Bellon Christine now holds 109,711 shares of BEAM.

This sale represents a 5.00% decrease in Bellon Christine's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Wednesday, April 1, 2026 and publicly disclosed via SEC Form 4 filing on Monday, April 6, 2026, 5 days after the trade was made.

Beam Therapeutics Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.